Chemoinformaics analysis of [(E)-DODEC-2-ENYL] ACETATE
| Molecular Weight | 226.36 | nRot | 10 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 29 |
| Exact Molecular Weight | 226.193 | nRing | 0 |
| Solubility: LogS | -3.646 | nHRing | 0 |
| Solubility: LogP | 3.27 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 42.3206 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.47 |
| Synth | 6.112 |
| Natural Product Likeliness | 1.024 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.904 |
| Pgp-sub | 0.954 |
| HIA | 0.9 |
| CACO-2 | -5.238 |
| MDCK | 0.00000323 |
| BBB | 0.458 |
| PPB | 0.82523 |
| VDSS | 0.724 |
| FU | 0.148854 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.075 |
| CYP2c19-inh | 0.105 |
| CYP2c19-sub | 0.864 |
| CYP2c9-inh | 0.322 |
| CYP2c9-sub | 0.516 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.456 |
| CYP3a4-inh | 0.923 |
| CYP3a4-sub | 0.774 |
| CL | 10.586 |
| T12 | 0.771 |
| hERG | 0.01 |
| Ames | 0.011 |
| ROA | 0.823 |
| SkinSen | 0.033 |
| Carcinogencity | 0.531 |
| EI | 0.004 |
| Respiratory | 0.066 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.78799 |